Atenolol (ATL)
Atenolol is a selective β1 receptor antagonist, a drug belonging to the group of beta blockers (sometimes written β-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. The chemical works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not pass through the blood–brain barrier thus avoiding various central nervous system side effects. Atenolol is used for a number of conditions including: hypertension, angina, Long cough, acute myocardial infarction, supraventricular tachycardia, ventricular tachycardia, and the symptoms of alcohol withdrawal. Atenolol is currently recommended only in special circumstances as complementary medication in hypertension.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Atenolol (ATL) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Atenolol (ATL) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Atenolol (ATL) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Atenolol (ATL) CLIA Kit Customized Service Offer
n/a ELISA Kit for Atenolol (ATL) ELISA Kit Customized Service Offer